Shelly Coe
Gynecology · Newport Beach, CANPI 1568716520
Payments from drug & device makers
Across 168 payments — averaging $7.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascend Therapeutics US, LLC$456
- Therapeuticsmd, Inc.$215
- Mayne Pharma Commercial LLC$193
- AbbVie$95
- Myriad Genetic Laboratories, Inc.$57
- Antares Pharma, Inc.$50
- plus $158 from 8 others
What the payments were for
- Food & beverage$1,12192%
- Gifts$1038%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascend Therapeutics US, LLC | 141 | $456 |
| Therapeuticsmd, Inc. | 4 | $215 |
| Mayne Pharma Commercial LLC | 7 | $193 |
| AbbVie(2 entities) | 4 | $95 |
| Myriad Genetic Laboratories, Inc. | 2 | $57 |
| Antares Pharma, Inc. | 1 | $50 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Mycovia Pharmaceuticals, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Avion Pharmaceuticals | 1 | $18 |
| Bayer | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,223 in reported general payments places this provider in the 55th percentile of 247 gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 312 | $31,920 |
| ProliaDenosumab | 12 | $20,538 |
| Estradiol (Twice Weekly)Estradiol | 171 | $19,748 |
| MounjaroTirzepatide | 11 | $11,104 |
| FemringEstradiol Acetate | 13 | $9,805 |
| DivigelEstradiol | 33 | $9,750 |
| ImvexxyEstradiol | 17 | $5,339 |
| ProgesteroneProgesterone, Micronized | 200 | $4,664 |
| YuvafemEstradiol | 19 | $4,332 |
| EstrogelEstradiol | 11 | $4,320 |
| DottiEstradiol | 32 | $3,009 |
| Estradiol (Once Weekly)Estradiol | 21 | $2,225 |
| SynthroidLevothyroxine Sodium | 12 | $1,634 |
| Clobetasol Propionate | 19 | $1,395 |
| ValacyclovirValacyclovir Hcl | 39 | $638 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $19 | $11,10411 claims |
| Vertical Pharmaceuticals, LLCDivigel | $29 | $9,75033 claims |
| Therapeuticsmd, Inc.Imvexxy | $215 | $5,33917 claims |
| Ascend Therapeutics US, LLCEstrogel | $456 | $4,32011 claims |
| AbbVieSynthroid | $95 | $1,63412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 247 gynecology providers in California.
Other gynecology in Newport Beach
- Nkiruka ChubaNewport Beach$7K
- Christine ChaiNewport Beach$4K
- Bruce LeeMonterey$2.8M
- Robert SemoSan Diego$2.8M
- Gioi Smith NguyenSan Diego$1.4M
- Barbara Levyla Jolla$780K
- Thomas EasterRancho Cucamonga$360K
- Babak EdrakiWalnut Creek$268K
- Samar NahasRiverside$132K
- Aarathi CholkeriEl Segundo$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.